MedTrace Logo

Skin Disease and Pulmonary Mortality After Transplantation

NCT03320928 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 79

Last updated 2017-10-26

No results posted yet for this study

Summary

Predictors for pulmonary mortality was determined in a cohort of 79 patients with acute-GVHD of the skin. The acute-GVHD treatment was corticosteroids and photochemotherapy (Photosensitization with oral 8-methoxysalen and Ultraviolet light type A) with or without concomitant methotrexate.

Conditions

  • Pulmonary Mortality
  • Acute GVH Disease

Interventions

OTHER

Photochemotherapy

Retrospective evaluation of treatment outcome and risk for pulmonary mortality and relapse incidence

Sponsors & Collaborators

  • Karolinska University Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-21
Primary Completion
2016-11-24
Completion
2016-11-24

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03320928 on ClinicalTrials.gov